Alseres Pharmaceuticals, Inc. Financial Ratios — ALSE Stock

Profitability (USD)

	1999 Y	2000 Y	2001 Y	2002 Y	2003 Y	2004 Y	2005 Y	2006 Y	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y
As of date	12/31/1999	12/31/2000	12/31/2001	12/31/2002	12/31/2003	12/31/2004	12/31/2005	12/31/2006	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-98.59	-57.88	-63.8	-110.18	-64.47	-112.63	-176.13	-409.1	-489.16	-644.54	-1,317.42	81.89	-913.07	-289.59	-139.36
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	1,245,550	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	100	100
EBITDA Margin (%)	-6,350	-571,427,450	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-228.16	-118.96
Operating Margin (%)	-6,350	-572,672,900	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-228.4	-119.21
Incremental Operating Margin (%)	- -	- -	-43,392,000	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-310.05	-198.75
Profit Margin (%)	-7,000	-532,713,200	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-310.05	-198.75
Net Income to Common Margin (%)	-9,700	-532,713,200	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-310.05	-198.75
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	27.84	- -	- -	- -	24.6	2.37	5.86	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	1999 Y	2000 Y	2001 Y	2002 Y	2003 Y	2004 Y	2005 Y	2006 Y	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y
As of date	12/31/1999	12/31/2000	12/31/2001	12/31/2002	12/31/2003	12/31/2004	12/31/2005	12/31/2006	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013

Total Debt	5	- -	- -	4	4	- -	- -	8	24	34	36	34	28	22	8
ST Debt	- -	- -	- -	- -	- -	- -	- -	8	- -	- -	36	34	28	6	- -
LT Debt	5	- -	- -	4	4	- -	- -	- -	24	34	- -	- -	- -	16	8
Total Debt/EBITDA	-0.36	- -	- -	-0.38	-0.5	- -	-0.02	-0.3	-1.25	-1.8	-4.32	-11.02	-18.19	-18.51	-13.88
Net Debt/EBITDA	-0.34	0.04	0.03	-0.3	0.3	0.02	0.05	-0.25	-1.09	-1.79	-8.4	-10.95	-18.1	-18.49	-13.67
Total Debt/EBIT	-0.36	- -	- -	-0.38	-0.48	- -	-0.02	-0.3	-1.25	-1.8	-4.28	-10.81	-17.72	-18.49	-13.85
Net Debt/EBIT	-0.34	0.04	0.03	-0.3	0.29	0.01	0.05	-0.25	-1.08	-1.78	-8.33	-10.75	-17.63	-18.47	-13.65
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-21.46	-8.42	-3.27	-1.16	-0.83	-2.79	-1.24
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-21.5	-8.49	-3.27	-1.16	-0.83	-2.79	-1.24
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	-21.55	-8.44	-3.3	-1.18	-0.85	-2.79	-1.24
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	1	2	3	3	2	- -	- -
Common Equity/Total Assets	55.9	-311.77	-654.86	-1,006.16	-539.62	-4,148.91	-1,112.49	-6,050.85	-2,895.69	-21,731.48	-24,585.11	-42,097.56	-115,236.26	-20,543.21	-51,710.43
Long-Term Debt/Equity (%)	47.92	- -	- -	137.09	31.46	- -	3.48	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	31.51	- -	- -	-4.72	-4.47	- -	-0.24	- -	-16.89	-22.4	-0.06	-0.02	- -	-9.11	-4.09
Long-Term Debt/Total Assets (%)	28.57	- -	- -	45.38	21.86	- -	2.61	- -	418.36	3,975.66	12.19	6.62	- -	1,656.82	2,028.68
Total Debt/Equity (%)	47.92	- -	- -	137.09	31.46	- -	3.48	-48.27	-105.16	-84.1	-75.05	-71.39	-91.65	-85.04	-76.15
Total Debt/Capital (%)	31.51	- -	- -	-4.72	-4.47	- -	-0.24	-5.91	-16.92	-22.43	-22.46	-21.08	-16.44	-12.76	-4.09
Total Debt/Total Assets (%)	28.57	- -	- -	45.38	21.86	- -	2.61	337.71	419.14	3,981.04	4,508.46	7,328.92	16,240.7	2,320.58	2,028.68
Net Debt to Equity	44.79	-2.14	-2.99	108.95	-18.8	-26.89	-7.33	-39.17	-91.02	-83.43	-145.96	-70.98	-91.2	-84.98	-75.04
Net Debt/Capital (%)	30.07	0.63	0.38	-3.72	2.49	0.15	0.49	-4.74	-14.35	-22.24	-43.59	-20.94	-16.35	-12.75	-4.03
EBITDA	-13	-11	-11	-10	-8	-10	-11	-26	-19	-19	-8	-3	-2	-1	-1
EBITDA-CapEx	-13	-11	-11	-11	-8	-10	-12	-26	-19	-19	-8	-3	-2	-1	-1
Operating Income (Loss)	-13	-11	-11	-10	-8	-10	-12	-26	-19	-19	-8	-3	-2	-1	-1

Liquidity (USD)

API ChatGPT

	1999 Y	2000 Y	2001 Y	2002 Y	2003 Y	2004 Y	2005 Y	2006 Y	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y
As of date	12/31/1999	12/31/2000	12/31/2001	12/31/2002	12/31/2003	12/31/2004	12/31/2005	12/31/2006	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013

Cash Ratio	8.33	11.9	5.71	3.8	7.28	0.83	3.97	0.08	1.13	0.03	0.01	- -	0.01	0.08	0.19
Current Ratio	8.67	12.32	6.04	4.03	7.92	0.91	4.18	0.1	1.38	0.06	0.01	- -	0.01	0.09	0.2
Quick Ratio	8.33	11.9	5.71	3.8	7.28	0.83	3.97	0.08	1.13	0.03	0.01	- -	0.01	0.08	0.19
CFO/Avg Current Liab	-4.57	-5.84	-5.22	-5.15	-4.68	-5.55	-4.9	-1.5	-2.17	-3.44	-0.34	-0.07	-0.07	-0.05	-0.29
Common Equity/Total Assets	55.9	-311.77	-654.86	-1,006.16	-539.62	-4,148.91	-1,112.49	-6,050.85	-2,895.69	-21,731.48	-24,585.11	-42,097.56	-115,236.26	-20,543.21	-51,710.43
Long-Term Debt/Equity (%)	47.92	- -	- -	137.09	31.46	- -	3.48	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	31.51	- -	- -	-4.72	-4.47	- -	-0.24	- -	-16.89	-22.4	-0.06	-0.02	- -	-9.11	-4.09
Long-Term Debt/Total Assets (%)	28.57	- -	- -	45.38	21.86	- -	2.61	- -	418.36	3,975.66	12.19	6.62	- -	1,656.82	2,028.68
Total Debt/Equity (%)	47.92	- -	- -	137.09	31.46	- -	3.48	-48.27	-105.16	-84.1	-75.05	-71.39	-91.65	-85.04	-76.15
Total Debt/Capital (%)	31.51	- -	- -	-4.72	-4.47	- -	-0.24	-5.91	-16.92	-22.43	-22.46	-21.08	-16.44	-12.76	-4.09
Total Debt/Total Assets (%)	28.57	- -	- -	45.38	21.86	- -	2.61	337.71	419.14	3,981.04	4,508.46	7,328.92	16,240.7	2,320.58	2,028.68
CFO/Total Liabilities	-123.08	-608.14	-501.06	-164.19	-146.96	-489.25	-403.96	-83.64	-87.11	-36.67	-16.69	-6.18	-8.17	-3.49	-15.83
CFO/CapEx	- -	-230.82	-16.7	-21.67	-179.69	-701.58	-120.25	-392.96	-661.66	-104.7	- -	- -	-1,047.11	- -	- -
Altman's Z-Score	9.38	17.79	7.11	-14.69	-4.09	-65.79	-12.38	-128.71	-50.16	-383.83	-444.2	-722.15	-1,858.59	-302.98	-732.74

Working Capital (USD)

API ChatGPT

	1999 Y	2000 Y	2001 Y	2002 Y	2003 Y	2004 Y	2005 Y	2006 Y	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y
As of date	12/31/1999	12/31/2000	12/31/2001	12/31/2002	12/31/2003	12/31/2004	12/31/2005	12/31/2006	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	-0.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	-25,359.75	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	25,359.75	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	1999 Y	2000 Y	2001 Y	2002 Y	2003 Y	2004 Y	2005 Y	2006 Y	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y
As of date	12/31/1999	12/31/2000	12/31/2001	12/31/2002	12/31/2003	12/31/2004	12/31/2005	12/31/2006	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013

Market Capitalization	110	63	55	25	38	19	26	46	57	26	5	3	7	2	1
- Cash & Cash Equivalents	- -	- -	- -	1	6	- -	1	2	3	- -	- -	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	1	- -	- -	- -	5	4	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	5	- -	- -	4	4	- -	- -	8	24	34	36	34	28	22	8
Enterprise Value	101	44	45	22	36	21	17	53	76	60	40	37	35	24	9
Total Capital	15	-65	-75	-82	-85	-102	-117	-135	-139	-150	-159	-160	-169	-176	-191
Total Debt/Capital (%)	31.51	- -	- -	-4.72	-4.47	- -	-0.24	-5.91	-16.92	-22.43	-22.46	-21.08	-16.44	-12.76	-4.09
Total Debt / EV	0.05	- -	- -	0.18	0.11	- -	0.02	0.15	0.31	0.56	0.89	0.92	0.79	0.92	0.91
EV/Sales	503.55	21,817,467.5	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	45.93	18.2
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	110	63	55	25	38	19	26	46	57	26	5	4	7	2	1
Diluted Enterprise Value	115	63	55	28	41	23	26	53	77	60	40	37	35	25	9
EV per Share	82,888.37	52,699.2	54,326	24,529.94	29,226.95	15,617.51	7,314.76	15,914.1	20,112.47	14,271.08	8,555.58	6,888.5	5,911.01	3,978.37	1,406.84
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -
TTM EBITDA	-13	-11	-11	-10	-8	-10	-11	-26	-19	-19	-8	-3	-2	-1	-1
TTM Operating Income	-13	-11	-11	-10	-8	-10	-12	-26	-19	-19	-8	-3	-2	-1	-1
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1	-1	-1
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1	-1	-1

Multiples (USD)

API ChatGPT

	1999 Y	2000 Y	2001 Y	2002 Y	2003 Y	2004 Y	2005 Y	2006 Y	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y
As of date	12/31/1999	12/31/2000	12/31/2001	12/31/2002	12/31/2003	12/31/2004	12/31/2005	12/31/2006	12/31/2007	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013

Price/Free Cash Flow	-13.76	-6.3	-6.51	-2.8	-4.87	-2.01	-2.5	-2.92	-2.32	-1.76	-0.58	-1.28	-2.86	-2.57	-0.43
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	101	44	45	22	36	21	17	53	76	60	40	37	35	24	9
Low Price	81,250	64,075	38,750	24,000	16,250	11,000	7,800	11,000	9,750	4,600	950	275	75	275	85
EV/Sales	503.55	21,817,467.5	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	45.93	18.2
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.25	- -	- -	- -
Price/Earnings Average	-8.24	-14.72	-6.57	-3.26	-3.98	-2.65	-2.16	-1.95	-2.63	-2.35	-1.65	12.26	-1.16	-3.01	-2.05
Price/Earnings High	-16.83	-31.33	-10.61	-7.54	-8.24	-5.04	-3.71	-2.66	-3.4	-3.09	-4.34	20.83	-5.24	-9.5	-4.88
Price/Earnings Low	-5.09	-4.98	-3.13	-1.95	-1.79	-1.27	-1.51	-1.38	-1.88	-0.92	-0.41	2.86	-0.15	-1.02	-0.55
Price/Book Value	12.23	-0.98	-0.74	-0.29	-0.4	-0.18	-0.23	-0.32	-0.35	-0.14	-0.02	-0.02	-0.04	-0.01	- -
Price/Book Value Average	17.76	-2.43	-0.9	-0.42	-0.47	-0.29	-0.23	-0.36	-0.32	-0.27	-0.09	-0.03	-0.02	-0.03	-0.01
Price/Book Value High	36.28	-5.17	-1.45	-0.97	-0.97	-0.56	-0.39	-0.49	-0.41	-0.35	-0.24	-0.06	-0.08	-0.08	-0.02
Price/Book Value Low	10.97	-0.82	-0.43	-0.25	-0.21	-0.14	-0.16	-0.25	-0.23	-0.1	-0.02	-0.01	- -	-0.01	- -
Price/Tangible Book Value	12.8	3.33	5.75	8.87	5.31	-6.6	3.34	-2.78	-2.53	-0.65	-0.1	-0.07	-0.23	-0.09	-0.07
Price/Tangible Book Value Average	18.59	8.23	7	12.69	6.2	-10.6	3.34	-3.09	-2.3	-1.22	-0.37	-0.13	-0.11	-0.19	-0.18
Price/Tangible Book Value High	37.97	17.52	11.31	29.37	12.84	-20.16	5.74	-4.23	-2.96	-1.61	-0.98	-0.23	-0.49	-0.58	-0.43
Price/Tangible Book Value Low	11.48	2.78	3.34	7.6	2.78	-5.1	2.33	-2.19	-1.64	-0.48	-0.09	-0.03	-0.01	-0.06	-0.05
Price/Sales	550.55	31,702,050	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.62	1.52
Price/Sales Average	799.2	78,433,983.93	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.35	4.07
Price/Sales High	1,632.66	166,893,750	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	29.44	9.7
Price/Sales Low	493.59	26,527,050	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.17	1.1
Price/Cash Flow	-13.76	-6.28	-6.12	-2.67	-4.84	-2	-2.48	-2.91	-2.32	-1.74	-0.58	-1.09	-2.86	-2.57	-0.43
Price/Cash Flow Average	-19.98	-15.53	-7.45	-3.82	-5.66	-3.21	-2.49	-3.24	-2.11	-3.27	-2.2	-2.13	-1.35	-5.21	-1.14
Price/Cash Flow High	-40.82	-33.04	-12.04	-8.85	-11.71	-6.12	-4.28	-4.42	-2.72	-4.31	-5.8	-3.62	-6.08	-16.4	-2.72
Price/Cash Flow Low	-12.34	-5.25	-3.55	-2.29	-2.54	-1.55	-1.74	-2.29	-1.51	-1.28	-0.55	-0.5	-0.18	-1.77	-0.31
Price/Free Cash Flow Average	-19.98	-15.59	-7.93	-4.01	-5.69	-3.22	-2.51	-3.25	-2.11	-3.3	-2.2	-2.52	-1.35	-5.21	-1.14
Price/Free Cash Flow High	-40.82	-33.18	-12.81	-9.28	-11.78	-6.12	-4.31	-4.43	-2.72	-4.35	-5.8	-4.28	-6.09	-16.4	-2.72
Price/Free Cash Flow Low	-12.34	-5.27	-3.78	-2.4	-2.55	-1.55	-1.75	-2.3	-1.51	-1.29	-0.55	-0.59	-0.18	-1.77	-0.31
EV/Sales Average	825.7	78,230,320.43	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	52.24	21.16
EV/Sales High	1,659.16	166,690,086.5	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	72.33	26.79
EV/Sales Low	520.09	26,323,386.5	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	46.07	18.19
EV/EBITDA Average	-13	-13.69	-6.37	-3.84	-6.1	-3.39	-2.28	-2.2	-3.84	-4.42	-6.43	-13.03	-20.53	-22.9	-17.79
EV/EBITDA High	-26.13	-29.17	-10.31	-8.5	-12.25	-6.15	-3.94	-2.92	-4.63	-5.26	-9.94	-14.47	-28.24	-31.7	-22.52
EV/EBITDA Low	-8.19	-4.61	-3.02	-2.43	-2.93	-1.8	-1.58	-1.63	-3.06	-2.83	-4.82	-11.46	-18.62	-20.19	-15.29
EV/EBIT Average	-13	-13.66	-6.33	-3.77	-5.93	-3.32	-2.24	-2.19	-3.82	-4.41	-6.38	-12.79	-19.99	-22.87	-17.75
EV/EBIT High	-26.13	-29.11	-10.25	-8.35	-11.9	-6.02	-3.87	-2.9	-4.61	-5.24	-9.86	-14.2	-27.51	-31.67	-22.47
EV/EBIT Low	-8.19	-4.6	-3.01	-2.38	-2.85	-1.76	-1.55	-1.62	-3.04	-2.82	-4.78	-11.25	-18.14	-20.17	-15.26
Last Price	90,625	76,575	66,750	28,000	31,000	14,250	11,150	13,950	15,000	6,250	1,000	600	1,200	400	117.5
High Price	268,750	403,125	131,250	92,750	75,000	43,500	19,200	21,200	17,600	15,450	10,000	2,000	2,550	2,550	750
Enterprise Value Average	165	156	67	39	47	34	26	58	72	82	53	40	31	28	10
Enterprise Value High	332	333	109	86	94	62	45	77	87	98	82	44	43	38	13
Enterprise Value Low	104	53	32	25	23	18	18	43	57	53	40	35	28	24	9

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	164.61	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	86.62	77.32
EBITDA per Share	-10,452.67	-13,802.6	-12,697.14	-11,315.1	-6,304.23	-7,478.42	-4,843.48	-7,944.04	-4,980.46	-4,467.88	-1,766.61	-574.17	-257.27	-197.63	-91.98
Operating Income per Share	-10,452.67	-13,832.68	-12,769.14	-11,523.5	-6,487.61	-7,639.02	-4,933.5	-7,998.41	-5,002.95	-4,480.56	-1,782.1	-585.15	-264.15	-197.84	-92.17
Basic EPS, GAAP	-15,967.08	-12,867.47	-12,367.41	-12,296.58	-9,097.28	-8,632.03	-5,174.48	-7,974.35	-5,179.74	-4,992.21	-2,306.71	96.01	-486.45	-268.56	-153.67
Basic EPS from Cont Ops	-11,522.63	-12,867.47	-12,367.41	-12,296.58	-6,859.01	-8,278.79	-4,871.43	-7,974.35	-5,179.74	-4,992.21	-2,306.71	96.01	-486.45	-268.56	-153.67
Diluted EPS, GAAP	-15,967.08	-12,867.47	-12,367.41	-12,296.58	-9,097.28	-8,632.03	-5,174.48	-7,974.35	-5,179.74	-4,992.21	-2,306.71	81.12	-486.45	-268.56	-153.67
Diluted EPS from Cont Ops	-11,522.63	-12,867.47	-12,367.41	-12,296.58	-6,859.01	-8,278.79	-4,871.43	-7,974.35	-5,179.74	-4,992.21	-2,306.71	81.12	-486.45	-268.56	-153.67
Dividend per Share	- -	- -	- -	- -	- -	148.46	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-6,584.36	-12,201.7	-10,901.23	-10,478.02	-6,405.05	-7,112.9	-4,489.95	-4,793.31	-6,471.46	-3,587.94	-1,725.24	-552.87	-419.38	-155.45	-275.33
Free Cash Flow per Basic Share	-6,584.36	-12,254.56	-11,554.01	-10,961.63	-6,440.7	-7,123.04	-4,527.29	-4,805.51	-6,481.24	-3,622.21	-1,725.24	-552.87	-419.78	-155.45	-275.33
Cash & Equivalents per Share	12,345.68	23,875.8	12,424	7,798.78	8,987.59	1,209.04	3,951.43	456.48	1,133.22	36.81	75.75	36.48	27.56	139.52	50.69
Book Value per Share	7,407.41	-77,989.1	-90,261.86	-95,977.89	-77,107.19	-77,687.94	-49,548.29	-43,369.98	-43,148.94	-43,985.95	-41,614.45	-36,330.9	-33,205.35	-32,379.17	-32,532.84
Tangible Book Value per Share	7,078.19	23,008.23	11,607.76	3,157.55	5,840.17	-2,157.91	3,342.36	-5,014.19	-5,939.18	-9,581.74	-10,168.95	-8,860.09	-5,164.93	-4,361.17	-1,739.81

Alseres Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)